Abstract: The invention provides pharmaceutical compositions comprising a protoporphyrin precursor photochemotherapeutic agent together with vascular stroma-localizing photosensitizers, optionally together with at least one surface penetration assisting agent and optionally with one or more chelating agents, and use of the same in treating disorders or abnormalities which are responsive to PDT, preferably exhibiting synergistically enhanced therapy, kits comprising same and methods of therapy and diagnosis.
Type:
Grant
Filed:
July 9, 1999
Date of Patent:
June 15, 2004
Assignee:
PhotoCure AS
Inventors:
Qian Peng, Jahn M. Nesland, Karl E. Giercksky, Johan Moan, Trond Warloe
Abstract: The present invention relates to a method for introducing molecules in cells by disrupting endosomal and lysosomal membranes using photodynamic treatment, without killing the majority of the cells by the photodynamic treatment. More particularly, this invention includes a method for transferring DNA and/or RNA, such as genes, to cells by photochemically inducing the disruption of endosomes and lysosomes.
Type:
Grant
Filed:
September 1, 1998
Date of Patent:
January 20, 2004
Assignee:
Photocure AS
Inventors:
Kristian Berg, Kirsten Sandvik, Johan Moan, Anders Høgset
Abstract: The present invention relates to a method for introducing molecules in cells by disrupting endosomal and lysosomal membranes using photodynamic treatment, without killing the majority of the cells by the photodynamic treatment. More particularly, this invention includes a method for transferring DNA and/or RNA, such as genes, to cells by photochemically inducing the disruption of endosomes and lysosomes.
Type:
Application
Filed:
November 1, 2002
Publication date:
July 17, 2003
Applicant:
Photocure AS
Inventors:
Kristian Berg, Kirsten Sandvik, Johan Moan, Anders Hogset
Abstract: The present invention relates to compounds being esters of 5-aminolevulinic acids or pharmaceutically acceptable salts thereof, including compounds of formula (I) R22N—CH2COCH2—CH2CO—OR1 (wherein R1 may represent alkyl optionally substituted by hydroxy, alkoxy, acyloxy, alkoxycarbonyloxy, amino, aryl, oxo or fluoro groups and optionally interrupted by oxygen, nitrogen, sulphur or phosphorus atoms; and R2 represents a hydrogen atom or a group R1, and both R2 groups may be the identical or different), and their use in diagnosis and photochemotherapy of disorders or abnormalities of external or internal surfaces of the body, and products and kits for performing the invention.
Type:
Grant
Filed:
December 21, 1999
Date of Patent:
December 10, 2002
Assignee:
PhotoCure AS
Inventors:
Karl E. Gierskcky, Johan Moan, Qian Peng, Harald Steen, Trond Warloe, Alf Bjorseth
Abstract: The invention provides a pharmaceutical compositions comprising a compound of formula I:R.sub.2.sup.2 N--CH.sub.2 COCH.sub.2 --CH.sub.2 CO--OR.sup.1(I)wherein, R.sup.1 and R.sup.2 have any of the values defined in the specification; or a salt thereof; and a pharmaceutically acceptable carrier or excipient. The invention also provides a method for the diagnosis or photochemotherapeutic treatment of disorders or abnormalities of external or internal surfaces of the body using such compounds or salts.
Type:
Grant
Filed:
December 5, 1997
Date of Patent:
March 7, 2000
Assignee:
PhotoCure AS
Inventors:
Karl E. Gierskcky, Johan Moan, Qian Peng, Harald Steen, Trond Warloe, Alf Bjorseth
Abstract: A method for releasing molecules into the cytosol of cells without killing the majority of the cells by allowing the molecules to be taken up in endosomes, lysosomes or other cell compartments and use light activation of photosensitizing compounds to rupture the membranes of the endosomes, lysosomes or other cell compartments, is described.
Type:
Grant
Filed:
March 28, 1997
Date of Patent:
March 2, 1999
Assignee:
Photocure AS
Inventors:
Kristian Berg, Kirsten Sandvig, Johan Moan